首页> 外文期刊>Journal of Veterinary Internal Medicine >Efficacy of an orally administered anti‐diarrheal probiotic paste (Pro‐Kolin Advanced) in dogs with acute diarrhea: A randomized, placebo‐controlled, double‐blinded clinical study
【24h】

Efficacy of an orally administered anti‐diarrheal probiotic paste (Pro‐Kolin Advanced) in dogs with acute diarrhea: A randomized, placebo‐controlled, double‐blinded clinical study

机译:口服止泻益生菌糊剂(Pro-Kolin Advanced)在急性腹泻犬中的功效:一项随机,安慰剂对照,双盲临床研究

获取原文

摘要

Background Acute diarrhea is a common clinical presentation of dogs. The effect of specific anti‐diarrheal probiotic pastes (ADPPs) in the management of acute, uncomplicated diarrhea in dogs is unknown. Hypothesis Administration of an ADPP containing Enterococcus faecium 4b1707 will improve the clinical outcome of acute, uncomplicated diarrhea in dogs compared to placebo. Animals One hundred forty‐eight client‐owned dogs with acute diarrhea as the main clinical sign. Methods Double‐blinded, placebo‐controlled, randomized, blocked, multicenter clinical field study conducted at 14 primary care veterinary practices in the United Kingdom and Ireland. Results The ADPP was associated with better clinical outcome compared to placebo in dogs with acute, uncomplicated diarrhea. Dogs in the ADPP group had a significantly shorter duration of diarrhea (ADPP: median, 32?hours; 95% confidence interval [CI], 2‐118; n ?=?51; Placebo: median, 47?hours; 95% CI, 4‐167; n ?=?58; P ?=?.008) and the rate of resolution of diarrhea was 1.60 times faster in the ADPP group than in the Placebo group (ratio, 1.60; 95% CI, 1.08‐2.44; P ?=?.02). Fewer dogs required additional medical intervention (AMI) for non‐improvement or worsening in the ADPP group compared to the Placebo group (3.5% of dogs and 14.8% of dogs, respectively), with a relative risk of 0.88 ( P ?=?.04; AMI, ADPP, 3.5%, 2/57 dogs; Placebo, 14.8%, 9/61 dogs; relative risk, 0.88; 95% CI, 0.77‐0.99). Conclusion and Clinical Importance The ADPP may accelerate resolution of acute diarrhea in dogs and decrease the requirement for AMI.
机译:背景技术急性腹泻是犬的常见临床表现。尚不知道特定的抗腹泻益生菌糊剂(ADPP)在犬急性,简单性腹泻中的作用。假设与安慰剂相比,含粪肠球菌4b1707的ADPP给药可改善犬急性,简单腹泻的临床疗效。动物一百四十八只以急性腹泻为主要临床症状的client养狗。方法在英国和爱尔兰的14种初级保健兽医实践中进行了双盲,安慰剂对照,随机,分组,多中心临床研究。结果与安慰剂相比,ADPP与急性,单纯性腹泻犬相比具有更好的临床效果。 ADPP组的狗的腹泻持续时间明显缩短(ADPP:中位数为32小时; 95%置信区间[CI]为2-118; n == 51;安慰剂:中位数为47小时; 95%CI ,4‐167; n?=?58; P?= ?. 008),腹泻解决率在ADPP组比安慰剂组快1.60倍(比率1.60; 95%CI,1.08-2.44) ;P≥= .02)。与安慰剂组相比,ADPP组中不需改善或加重病情的狗就更少了,分别为3.5%的狗和14.8%的狗,相对风险为0.88(P?=?)。 04; AMI,ADPP,3.5%,2/57只狗;安慰剂,14.8%,9/61只狗;相对风险,0.88; 95%CI,0.77-0.99)。结论和临床意义ADPP可以加速狗急性腹泻的缓解,并降低对AMI的需求。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号